Sun Pharmaceuticals Industries Ltd Share Price
SECTOR : Pharmaceuticals | BSE :524715 | NSE : SUNPHARMA
Aug 08, 2022 04:01 PM
Sun Pharmaceutical Industries Announced Q1FY23 Result :
Dilip Shanghvi, Managing Director of the Company said, “For Q1, all our businesses recorded good growth, driven by a combination of sustained scale-up for our specialty business and all-round growth across markets. Specialty business has grown by 29% driven by Ilumya, Cequa, Odomzo and Winlevi. Our India business continues to grow faster than market, leading to increase in market share. We have been able to report healthy margins despite rising costs. We continue to focus on expanding our global specialty business, growing all our businesses and improving our market share.”
Date | Action Type | Ratio |
---|---|---|
Aug 19, 2022 | Dividend | 300 |
Feb 09, 2022 | Dividend | 700 |
Aug 23, 2021 | Dividend | 200 |
AGM Date (Month) | : | Aug |
Face Value Equity Shares | : | 1 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 524715 |
NSE Code | : | SUNPHARMA |
Book Closure Date (Month) | : | Aug |
BSE Group | : | A |
ISIN | : | INE044A01036 |